Printed from Voxsanity (voxsanity.com.au) — NCT07550140 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Sleep Disorders
Sleep Disorders Trial, Recruiting
NCT07550140
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 60 and 80 years old
- People with normal vision and hearing (without aids)
- People with a body mass index (BMI) between 18.5 and 30 (a measure of body weight relative to height)
- People who have mild to moderate self-reported concerns about their memory or thinking abilities
Who may not be able to join:
- People who smoke
- People who have food allergies
- People who follow a restrictive or unbalanced diet, such as a vegetarian, vegan, weight-reducing, or other special diet
- People who have been diagnosed with a psychiatric or neurological condition, such as schizophrenia, depression, dementia, or an eating disorder
- People who have been diagnosed with a heart or metabolic condition, including type 2 diabetes, cardiovascular disease, high blood pressure, clotting disorders, or thyroid disease
- People currently taking blood thinners, anti-clotting medications, antidepressants, or stomach acid-reducing medications (proton-pump inhibitors)
- People currently taking prebiotic or probiotic supplements
- People who have taken antibiotics continuously for more than 3 days within the month before joining the trial
- People who have used a weight-loss medication continuously for more than 1 month before screening
- People with a significant gut condition that affects how the body absorbs nutrients, including inflammatory bowel disease, irritable bowel disease, removal of the large bowel, weight-loss surgery, advanced kidney disease, or active cancer or cancer treatment within the last 3 years
- People with a history of claustrophobia (fear of enclosed spaces)
- People fitted with a pacemaker or artificial heart valve
- People with active implants such as cochlear (hearing), ocular (eye), or penile implants
- People who have metal fragments such as shrapnel anywhere in their body
- People with a drug infusion pump installed in their body
- People with any surgically implanted metal in the body, other than standard dental fillings or crowns (for example, joint replacements or bone reconstruction hardware)
- People who have had surgery that may have involved metal implants
- People with a current or past history of epilepsy
- People with nerve, brain, or bone stimulators installed
- People with an intrauterine contraceptive device (IUD) in place
- People who wear transdermal (skin) patches that contain metal
- People who wear dental fillings, crowns, dental posts related to root canal treatment, retainers, bridges, or braces (confirm with trial site)
- People who would need to remove coloured contact lenses, nail polish, or makeup for scanning sessions
- People who wear hearing aids
- People with body piercings that cannot or will not be removed for the scanning session
- People with tattoos or permanent makeup
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: +44 118 378 5818
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
University of Reading
Registry
ClinicalTrials.gov
Start date
5 May 2026
Est. completion
31 December 2027
Where this trial is recruiting
🇬🇧 United Kingdom
Primary endpoints
Montreal Cognitive Assessment (MoCA) score; fMRI; MRS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.